Lingli Chen
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced biosensing and bioanalysis techniques 6
- RNA Interference and Gene Delivery 4
- Gut microbiota and health 4
- Oncology 20
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Yaping Li (13 shared papers)Haijun Yu (11 shared papers)Qi Yin (9 shared papers)Wangwen Gu (11 shared papers)Zhiwen Zhang (10 shared papers)Qingshuo Meng (7 shared papers)Jinghan Su (6 shared papers)Huiping Sun (5 shared papers)
- Journals
- Advanced Functional Materials (5 papers)Cancer Management and Research (3 papers)Abdominal Radiology (3 papers)Frontiers in Microbiology (2 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lingli Chen
101 papers receiving 4.1k citations
Lingli Chen's Hit Papers
Peers
Comparison fields: 5 of 123
- Hepatology 399
- Biomaterials 743
- Geriatrics and Gerontology 115
- Biomedical Engineering 1.1k
- Oncology 581
Countries citing papers authored by Lingli Chen
This map shows the geographic impact of Lingli Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli Chen more than expected).
Fields of papers citing papers by Lingli Chen
This network shows the impact of papers produced by Lingli Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli Chen. The network helps show where Lingli Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingli Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors Hit paper breakdown → | 2016 | 556 |
| 2 | 2016 | 321 | |
| 3 | 2019 | 299 | |
| 4 | 2018 | 221 | |
| 5 | 2012 | 198 | |
| 6 | Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations Hit paper breakdown → | 2021 | 163 |
| 7 | 2015 | 128 | |
| 8 | The Interaction between Flavonoids and Intestinal Microbes: A Review Hit paper breakdown → | 2023 | 114 |
| 9 | 2014 | 112 | |
| 10 | 2015 | 108 | |
| 11 | 2013 | 99 | |
| 12 | 2012 | 96 | |
| 13 | 2018 | 96 | |
| 14 | 2015 | 88 | |
| 15 | 2021 | 87 | |
| 16 | 2016 | 87 | |
| 17 | 2018 | 63 | |
| 18 | 2011 | 61 | |
| 19 | 2013 | 58 | |
| 20 | 2021 | 50 |
About Lingli Chen
Lingli Chen is a scholar working on Molecular Biology, Oncology, Surgery, Biomedical Engineering and Biomaterials, having authored 107 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), RNA Interference and Gene Delivery (4 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Hepatology (399 citations), Biomaterials (743 citations), Geriatrics and Gerontology (115 citations), Biomedical Engineering (1.1k citations) and Oncology (581 citations). Lingli Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yaping Li, Haijun Yu, Qi Yin, Wangwen Gu, Zhiwen Zhang, Qingshuo Meng, Jinghan Su, Huiping Sun, Yuan Ji and Pengcheng Zhang. Their work appears in journals such as Advanced Functional Materials, Cancer Management and Research, Abdominal Radiology, Frontiers in Microbiology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.